Not Signed In - Positive Results With Rotigotine In Restless Legs Syndrome In Second Phase III Trial - First Results From The Second Phase III Trial With Rotigotine
Sat, 13 Jan 2007 11:00 PM EST
... SCHWARZ PHARMA announced today that a second phase III trial with rotigotine transdermal patch for the treatment of the signs and symptoms of moderate to severe Restless Legs Syndrome (RLS) has shown a clinically relevant and statistically significant reduction of RLS symptoms versus placebo in both primary variables. Rotigotine was also well tolerated in this trial. [click link for full article] ...
Related Topics
- Clinical Trials
- Restless Legs Syndrome
- Antithrombin III
- Familial Dysautonomia
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Restless Legs Syndro
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Congenital antithrombin III deficiency
- Cranial mononeuropathy III - diabetic type
- Cranial mononeuropathy III - compression type
- Antithrombin
- Osteogenesis imperfecta, type III
- Restless Leg Syndrome
- Desipramine
- Trastuzumab
- Amniocentesis
- Eletriptan
- Tarceva
- CK
email this page
print this page
bookmark this page
feedback on this page
